But this is the first-known case of a brain tumor caused by a brain stem cell therapy, according to the report-a phenomenon scientists have predicted in the pages of Scientific American and elsewhere.

Though brain tumor stem cells are low proportion in tumor tissue, they are the key for maintaining malignance.

There is overwhelming evidence that the tumor clone including brain tumor is heterogeneous with respect to both morphology and function, which indicates differentiation potential of tumor stem cells.